Osteoporosis Disease Management Demonstration Project (0000-040)

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD)

Status

Completed

Conditions

Osteoporosis

Treatments

Behavioral: Disease Management Assessment

Study type

Interventional

Funder types

Industry

Identifiers

NCT00145067
0000-040
2005_051
040

Details and patient eligibility

About

The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.

Enrollment

230 patients

Sex

Female

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Members of of the Kaiser Permanente Health Plan who have fractured a bone.

Exclusion criteria

Individuals who are not members of the Kaiser Permanente Health Plan.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems